Journal of Infectious Diseases and Medical Microbiology

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (202) 780-3397

Short Communication - Journal of Infectious Diseases and Medical Microbiology (2025) Volume 9, Issue 3

Eukaryotic Pathogens: Understanding Their Impact on Human Health

Hui Clark*

School of Life Sciences, Faculty of Science, University of Technology, Australia

*Corresponding Author:
Hui Clark
School of Life Sciences, University of Technology, Australia
E-mail: clarkh@nwpu.edu.cn

Received: : 03-May-2025, Manuscript No. AAJIDMM- 25- 165779; Editor assigned: 05-May-2025, PreQC No. AAJIDMM- 25-165779 (PQ); Reviewed: 11-May-2025, QC No. AAJIDMM- 25-165779; Revised:25-May-2025, Manuscript No. AAJIDMM- 25-165779 (R); Published: 31-May-2025, DOI:10.35841/10.35841/aajidmm-9.3.262

Citation: Citation: Clark H. Eukaryotic Pathogens: Understanding Their Impact on Human Health. 2025; 9(3):262

Abstract

  

Introduction

Eukaryotic pathogens are a diverse group of microorganisms that can cause a wide range of diseases in humans. Unlike bacteria and viruses, which belong to simpler cellular structures, eukaryotic pathogens have a complex cellular architecture and include fungi, protozoa, and certain parasites. These organisms often require specialized mechanisms to evade the host immune system, and their ability to infect and cause disease in humans presents unique challenges for diagnosis, treatment, and prevention. [

Understanding the biology and behaviour of eukaryotic pathogens is crucial for developing effective strategies to combat infections caused by these organisms. Fungal infections have emerged as significant contributors to human disease, particularly in immunocompromised individuals. Fungi are eukaryotic organisms that can exist as unicellular yeasts or multicellular moulds. They are capable of invading various body tissues, leading to infections ranging from superficial skin conditions to life-threatening systemic diseases. Candida albicans is the most well-known species responsible for causing candidiasis, an infection that can affect mucous membranes, the skin, and internal organs. In immunocompromised patients, such as those with HIV/AIDS or cancer, Candida can cause invasive infections leading to sepsis and organ failure.[

Protozoa are single-celled eukaryotic organisms that can cause a variety of diseases, particularly in tropical and subtropical regions. They are transmitted through contaminated food, water, or vectors like mosquitoes. The protozoan parasite responsible for malaria, Plasmodium falciparum and other species are transmitted through the bites of infected Anopheles mosquitoes. Malaria remains one of the deadliest diseases in the world, causing millions of deaths annually, particularly in sub-Saharan Africa. Leishmaniasis is caused by protozoa of the Leishmania genus, transmitted through the bites of infected sand flies. The disease manifests in various forms, ranging from cutaneous lesions to visceral leishmaniasis, which can affect internal organs and be fatal if untreated. [5, 6].

Helminths are multicellular eukaryotic organisms, often referred to as parasitic worms. While they are larger than protozoa, their lifecycle and transmission to humans often involve complex interactions with the host. Schistosomiasis is caused by flukes of the Schistosoma genus, which are transmitted through contaminated water. The adult worms can live in blood vessels, where they release eggs that cause inflammation and tissue damage. Chronic infection can lead to liver fibrosis, bladder cancer, and kidney failure. A large roundworm that causes ascariasis, Ascaris larvae migrate through the body, causing damage to organs such as the lungs, liver, and intestines. It is commonly found in regions with inadequate sanitation.[7].

Many eukaryotic pathogens, such as Candida species and Plasmodium, express surface molecules that allow them to adhere to epithelial cells or immune cells, facilitating invasion and colonization. Eukaryotic pathogens can evade immune detection through several mechanisms. For example, Leishmania parasites inhibit macrophage activation, while Trypanosoma species can change their surface antigens to avoid detection by the immune system. Protozoa like Plasmodium and Trypanosoma can invade host tissues and organs, causing direct damage. Fungi like Aspergillus can form biofilms that protect them from immune responses and antifungal treatments. Some eukaryotic pathogens, such as certain species of fungi and helminths, produce toxins that damage tissues and contribute to disease. For example, Aspergillus species can produce mycotoxins that exacerbate lung damage during infection. [8, 9].

Identifying eukaryotic pathogens, such as Plasmodium species in blood smears or Candida in tissue samples, is an essential diagnostic technique. Molecular methods, such as polymerase chain reaction (PCR) and enzyme-linked immunosorbent assay (ELISA), can detect specific eukaryotic pathogens in clinical samples. For some infections, serological tests to detect antibodies or antigens can provide important diagnostic information, particularly in diseases like leishmaniasis and Chagas disease. Drugs like fluconazole, amphotericin B, and echinocandins are used to treat fungal infections. Treatment duration depends on the severity of the infection and the immune status of the patient. [10].

conclusion

Eukaryotic pathogens represent a complex and varied group of organisms that cause significant morbidity and mortality worldwide. From fungal infections that affect immunocompromised individuals to protozoal and helminthic diseases that burden tropical populations, these pathogens pose unique challenges in the fields of medicine and public health. Advancing our understanding of their biology, pathogenesis, and mechanisms of resistance, coupled with improved diagnostic and treatment strategies, is essential for effectively controlling and preventing diseases caused by eukaryotic pathogens. As global travel and climate change continue to influence the spread of these infections, a coordinated approach to research, prevention, and treatment will be necessary to mitigate their impact on human health.

References

  1. Banerji R, Kanojiya P, Patil A, et al. Polyamines in the virulence of bacterial pathogens of respiratory tract. Mol Oral Microbiol. 2021;36(1):1-1.

    2. Indexed at, Google Scholar, Cross Ref

  2. Saur IM, Hückelhoven R. Recognition and defence of plant-infecting fungal pathogens. J Plant Physiol. 2021;256:153324.

    3. Indexed at, Google Scholar, Cross Ref

  3. Leitão JH. Microbial virulence factors. Int J Mol Sci. 2020;21(15):5320.

    4. Indexed at, Google Scholar, Cross Ref

  4. Ahmad-Mansour N, Loubet P, Pouget C, et al. Staphylococcus aureus toxins: an update on their pathogenic properties and potential treatments. Toxins. 2021;13(10):677.

    5. Indexed at, Google Scholar, Cross Ref

  5. Loh E, Righetti F, Eichner H, et al. RNA thermometers in bacterial pathogens. Microbiol Spectr. 2018;1:55-73.

    6. Indexed at, Google Scholar, Cross Ref

  6. Schröter L, Dersch P. Phenotypic diversification of microbial pathogens—cooperating and preparing for the future. J Mol Biol. 2019;431(23):4645-55.

    7. Indexed at, Google Scholar, Cross Ref

  7. Weinert LA, Welch JJ. Why might bacterial pathogens have small genomes?. Trends Ecol Evol. 2017;32(12):936-47.’

    8. Indexed at, Google Scholar, Cross Ref

  8. Sheppard SK. Strain wars and the evolution of opportunistic pathogens. Curr Opin Microbiol. 2022;67:102138.

    9. Indexed at, Google Scholar, Cross Ref

  9. Wilson D. The role of zinc in the pathogenicity of human fungal pathogens. Adv Appl Microbiol. 2021;117:35-61.

    10. Indexed at, Google Scholar, Cross Ref

  10. Pilla G, Tang CM. Going around in circles: virulence plasmids in enteric pathogens. Nat Rev Microbiol. 2018;16(8):484-95.

    11. Indexed at, Google Scholar, Cross Ref

Get the App